Sol J. Barer, Director at NexImmune, Inc. (NEXI), bought 139,280 shares at $2.35 ($312K) on 2022-06-01, disclosed to the SEC on 2022-06-02.
Open-market purchase of $312k NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.19 | 39,280 | $86K | 27.6% |
| 2 | $2.19 | 39,280 | $86K | 27.6% |
| 3 | $2.35 | 40,000 | $94K | 30.1% |
| 4 | $2.22 | 20,720 | $46K | 14.7% |
| Total | $2.24 avg | 139,280 | $312K | 100% |
| Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |
| NEXI | BUY | 2022-03-22 | $128K | — | Filing → |